IP Library Granted Patent US 7,986,995
Granted Patent B2
US 7,986,995 · App. 11/656,121 · Granted Jul 26, 2011

Bulimia treatment

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,986,995
App. No.
11/656,121
Granted
Jul 26, 2011
Kind
B2
Abstract

At least one of a plurality of disorders of a patient characterized at least in part by vagal activity innervating at least one of a plurality of organs of the patient is treated by a method that includes positioning an electrode on a vagus nerve. An electrical signal is applied to the electrode to modulate vagal activity by an amount selected to treat the disorder. In some embodiments, the disorder is bulimia. The signal may be a blocking or a stimulation signal. In some embodiments, the signal is selected to, at least in part, downregulate neural activity on the vagus nerve.

Claims (15)

1. A method for treating bulimia comprising:

positioning an electrode on a vagus nerve at a site below a vagal innervation of a heart of a patient having bulimia, with the nerve innervating at least one of a plurality of alimentary tract organs; and

treating the patient's bulimia by applying an electrical signal to the electrode, wherein the electrical signal is selected to a) at least in part, downregulate neural activity on the vagus nerve; b) allow at least partial restoration of nerve activity following discontinuation of application of the signal to the nerve; and c) have a frequency of at least 500 Hz; wherein the electrical signal is applied without simultaneously applying an electrical signal that upregulates afferent neural activity.

2. A method according to claim 1 wherein application of the neural conduction block is variable by a controller to alter a characteristic of the block.

3. A method according to claim 1 wherein the signal is regulated to reduce a pancreatic output of the patient.

4. A method according to claim 1 wherein the electrode is placed at the vagus nerve at an esophagus of the patient.

5. A method according to claim 1 wherein the signal has a frequency of about 5,000 Hz.

6. A method according to claim 1 wherein the signal is intermittently applied.

7. A method according to claim 1 wherein the signal is applied to a trunk of the vagus nerve.

8. A method according to claim 1 wherein the signal is applied to a branch of the vagus nerve.

9. A method according to claim 1 wherein the signal is applied to both an anterior vagus nerve and a posterior vagus nerve of the patient.

10. A method according to claim 1 wherein the signal is applied to the vagus nerve at a location near or distal to a diaphragm of the patient.

11. A method according to claim 1 wherein the signal is selected to at least partially block afferent nerve signals.

12. A method according to claim 1 wherein the signal is selected to at least partially block efferent nerve signals.

13. A method according to claim 1 wherein the signal is selected to at least partially block both afferent and efferent nerve signals.

Assignments (1)
CHANGE OF NAME Recorded Mar 30, 2018
From: ENTEROMEDICS INC.
To: RESHAPE LIFESCIENCES INC.
Reel/Frame 045949/0495 →